Article Versions Notes

Padrik P, Tõnisson N, Hovda T, Sahlberg KK, Hovig E, Costa L, Nogueira da Costa G, Feldman I, Sampaio F, Pajusalu S, et al. Guidance for the Clinical Use of the Breast Cancer Polygenic Risk Scores. Cancers. 2025; 17(7):1056. https://doi.org/10.3390/cancers17071056

Padrik, Peeter, Neeme Tõnisson, Tone Hovda, Kristine Kleivi Sahlberg, Eivind Hovig, Luís Costa, Gonçalo Nogueira da Costa, Inna Feldman, Filipa Sampaio, Sander Pajusalu, and et al. 2025. "Guidance for the Clinical Use of the Breast Cancer Polygenic Risk Scores" Cancers 17, no. 7: 1056. https://doi.org/10.3390/cancers17071056

Padrik, P., Tõnisson, N., Hovda, T., Sahlberg, K. K., Hovig, E., Costa, L., Nogueira da Costa, G., Feldman, I., Sampaio, F., Pajusalu, S., Ojamaa, K., Kallak, K., Tihamäe, A.-T., Roht, L., Kahre, T., Lepland, A., Sõber, S., Kruuv-Käo, K., Tamm, M., ... Evans, D. G., on behalf of the AnteNOR and BRIGHT Research Consortia. (2025). Guidance for the Clinical Use of the Breast Cancer Polygenic Risk Scores. Cancers, 17(7), 1056. https://doi.org/10.3390/cancers17071056